QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.

Press

19Jul 2026

Pragmatic trials and RWE in focus at SCRI 2026

We are pleased to share that Kelsi Smith, Senior Project Lead, Real-World Evidence and Analytics at Quantify Research, will be speaking at the Singapore Clinical Research Institute (SCRI) Trials Symposium 2026 in Singapore.

Kelsi will join the session as one of the guest speakers:
Pragmatic & Real-World Evidence Studies
📅 30 July | 15:00–16:30
📍 Track 3: Innovations in Trial Design & Methodology

The session will explore how […]

7Jul 2026

JCA learnings: Sharing expertise across the athagoras Group

Our Market Access Strategy unit recently held a workshop focused on Joint Clinical Assessment (JCA) learnings.

The session brought together perspectives from Quantify Research and our sister companies within the athagoras Group creating a valuable opportunity to learn from practical experience in JCA dossier preparation and strategy.

Together, we explored:
📌key considerations in preparing a JCA dossier
📌 how evidence planning connects to access strategy
📌 learnings from […]

6Jul 2026

New starter | From internship to Research Analyst

We are pleased to welcome Pankaj Khajuria as a Research Analyst in our Evidence, Review and Synthesis unit Quantify Research India.

Pankaj first joined Quantify Research as an ERS Intern where he contributed to systematic literature reviews, evidence synthesis, and HEOR projects.

He brings a strong academic foundation in pharmacology, toxicology, and biomedical research.

Pankaj completed his Bachelor of Pharmacy, followed by an M.Pharm. in Pharmacology at the University Institute of Pharmaceutical […]

3Jul 2026

A week of connection across the athagoras group

A good week in evidence, access, and collaboration.

Last Monday, 22 June, we had the pleasure of hosting Giuseppe Pileggi, CEO of athagoras, for the athagoras Townhall in Stockholm.

It was a valuable opportunity to connect as a group, share perspectives, and discuss how we continue building specialist European capabilities across RWE, HEOR, market access, and regulatory affairs.

We also warmly welcome […]